CVM
NVAX icon

Cheviot Value Management’s Novavax NVAX Stock Holding History

Cheviot Value Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433 Buy
+46
New +$412 ﹤0.01% 407
2025
Q2 		– Sell
-15
Closed -$94 – 453
2025
Q1 		$94 Buy
+15
New +$124 ﹤0.01% 441

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Cheviot Value Management's NVAX Position: Q2 2026 in Review

Cheviot Value Management opened a new position in Novavax (NVAX) in Q2 2026: 46 shares worth $433. The stake represents ﹤0.01% of the portfolio and ranks #407 among its holdings. This is a return to the name: Cheviot Value Management previously reported a position in NVAX as recently as Q1 2025.

Cheviot Value Management first reported a position in NVAX in Q1 2025 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Cheviot Value Management held 46 shares of Novavax worth $433 as of Q2 2026.
  • Novavax was a new Cheviot Value Management position in Q2 2026.
  • Novavax made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #407 holding.
  • Cheviot Value Management first reported a position in Novavax in Q1 2025 and has held it in 2 quarters since.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.